Patient Referral Resources
Finde out how to put your physician in touch with us to request an appointment. More information for Patients to help reach our Doctors
Read more »
Building the Profile:
Family History + Genetic Data
Our Risk Assessment Program (RAP) was one of the first in the nation to offer screening, education, and counseling to healthy people at increased genetic risk for disease.
A combination of your family history and your genetic data is used to build a profile of your risk for all cancer types, including — but not limited to — breast, ovarian, uterine, gastrointestinal (including colon), prostate, thyroid, and melanoma.
Clinical Genetics Staff List
Mary B. Daly, MD, PhD, FACP, Chair, Clinical Genetics,
Chair, Clinical Genetics
Timothy R. Talbot Jr. Chair for Cancer Research; Co-Leader, Keystone Program in Personalized Risk and Prevention
Michael J. Hall, MD, MS, Director, Clinical Risk Assessment, Clinical Genetics,
Director, Clinical Risk Assessment for Gastrointestinal Risk
Elias Obeid, MD, MPH, Attending Physician, Hematology/Oncology, Clinical Genetics,
Assistant Professor, Breast, Ovarian, and Prostate Cancer Risk Assessment
The Department of Clinical Genetics is closely aligned with ongoing research initiatives in Fox Chase's Cancer Prevention and Control Program, as well as its , a collaborative translational science program co-led by Daly and funded through philanthropic donations to Fox Chase.
Learn more about what Cancer Risk Assessment can mean for you and your family.